ceo response, page-37

From the CEO Blog



Roger wrote, about 7 hours ago



Very impressive. Look forward to the glioblastoma related results.

As for why the news does not make an impact, although this is all very nice, it is still a bit of story telling, isn't it? What I mean is, what are the quantitative aspects of this anti-cancer effectiveness? Were 100% of the tumors destroyed 100% as one is left to imagine, or was it something less dramatic? Will Dr. Mor publish the data?




graham kelly wrote, about 38 minutes ago


In reply to Roger.

Some of the data is in the process of being loaded up on the CanTx website. Give us until the end of the week to get it up. I think you will find it impressive.

Trx-1 (in Captisol) gave a very substantial reduction in tumor load compared to Captisol-only mice.

Two things to bear in mind.

First, that this is a model that previously has failed to respond to any experimental drug in any way, not even stabilised disease. Second, this was not a study intended to measure the effect of Trx-1 as a final product. The final product is Trx-1 in a targeted construct. That's what we are focusing on and that is what Dr Mor will be presenting to a conference in June.

Graham Kelly